Fluorescent In Situ Hybridisation (FISH) testing for Myelodysplastic syndrome
A targeted FISH panel to exclude common abnormalities with prognostic significance in Myelodysplastic syndrome
Myelodysplastic syndrome FISH panel
For diagnosis, classification and prognosis in haem-oncology
Del(5q), Del(7q), CEP8, MLL(KMT2A), ETV6, Del(20q), EVI1(MECOM)
FISH
2 - 14 days
77314 – criteria applies
If not MBS eligible, please contact 1800 822 999 for pricing details
Standard pathology request form
Bone marrow aspirate in lithium heparin tube
Bone marrow
Doctor collect. No additional sample required. Test is performed with chromosome analysis.
